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Introduction. The aim of this study was to estimate the prevalence of malaria among women giving birth in Bangui. Association
between sociodemographic characteristics of those women and malaria, as well as prevention compliance (use of intermittent
preventive treatment with sulfadoxine-pyrimethamine (IPTsp) and insecticide-treated bed nets (ITNs)), was analyzed. Methods.
During September 2009, a survey was conducted on 328 women who gave birth at two main maternities of Bangui. Information
was obtained by standardized questionnaire about sociodemographic criteria, IPTsp, other antimalarial treatment, and use of bet
nets. Smears prepared from peripheral and placental blood were analysed for malaria parasites. Findings and Discussion. Positive
results were found in 2.8% of thick peripheral blood smears and in 4.0% of placental slides. A proportion of 30.5% of the women
had received at least two doses of IPTsp during the current pregnancy. Only a proportion of 42.4% of this study population had
ITNs. Multigravid women were less likely to use IPTsp and ITNs. However, use of IPTsp was associated with personal income and
secondary or university educational status. Hence, although this relatively prevalence was observed, more eﬀorts are needed to
implement IPTsp and ITNs, taking into account sociodemographic criteria.
1.Introduction
Every year, it is estimated that tens of thousands of pregnant
women in malaria-endemic areas are infected with Plasmod-
ium falciparum [1]. Frequently, placental infection occurs,
owing to the accumulation of P. falciparum-infected erythro-
cytesintheintervillousspace,despitetheabsenceofparasites
in peripheral blood [2]. The complications of malaria dur-
ing pregnancy are maternal anaemia, preterm delivery, and
low birth weight of newborns, which increase perinatal
morbidity [1, 3, 4]. The World Health Organization
(WHO)recommendsintermittentpreventivetreatmentwith
sulfadoxine-pyrimethamine (IPTsp) during pregnancy, with
at least two doses after quickening (18–20 weeks) not more
frequently than monthly, use of insecticide-treated bed nets
(ITNs) and prompt treatment of clinical malaria [5]. Inter-
mittent preventive treatment consists of delivering a curative
treatment dose of an antimalarial at predeﬁned intervals,
regardless of the parasitological status of the woman, and the
eﬃcacy of this protocol has been demonstrated in a number
of malaria-endemic countries [5–8].
Placental Plasmodium screening in the Central African
Republic (CAR) in 1990 showed a rate of 37.1% in women
whohadbeengivenchemoprophylaxiswithchloroquine[9].2 Journal of Tropical Medicine
In 2006, the Ministry of Health of the CAR adopted and
implemented the new WHO recommendations for malaria
prevention during pregnancy. The aim of the study reported
here was to estimate the prevalence of malaria in thick peri-
pheral blood smears and placental blood from a sample of
women who gave birth during September 2009 at two main
maternities of Bangui, the capital of CAR. Secondly, we asse-
ssed the women’s coverage rates with the three components
of the WHO package [10] for malaria management during
the current pregnancy and identify pregnant women charac-
teristics associated with IPTsp and ITNs.
2. Methods
2.1. Study Setting. We conducted a cross-sectional study in
the two main maternity clinics of Bangui, the Castors health
Centre and the “Communautaire” Hospital, in September
2009. The geographic coordinates of Bangui is 7◦.00  north
and 21◦.00  east. The climate is tropical, and rainfall peaks
areobservedfromApriltoNovember,andtemperaturerang-
esfrom19◦Ct o32 ◦C.ThemainparasiteisPlasmodiumfalci-
parum, and malaria transmission is perennial with peaks
during the rainy season, but no data on the intensity of
malaria transmission (entomological inoculation rates) is
available in CAR. Malaria represents more than 40% of mor-
bidity in Bangui, as well as in other CAR areas [11].
The Castors Health Centre and the “Communautaire”
Hospital provide antenatal and delivery services and have
established programmes for the prevention of malaria and
other infectious diseases, such as mother-to-child transmis-
sion of HIV infection. Each year, it is estimated that 12,000
women deliver at those centres, representing 70% of all
women who deliver in Bangui. All women are screened for
malaria by microscopic analysis of 4% Giemsa-stained thick
bloodsmearsduringvisitstotheantenatalclinics,performed
either at the same health centre or at one of the national
reference biomedical laboratories (the National Laboratory
for Clinical Biology and Public Health and the Institut Pas-
teur de Bangui), depending on each woman’s choice. Anti-
malarial treatment is prescribed on the basis of clinical sym-
ptoms if the woman cannot aﬀord the laboratory fees
immediately.
Forasymptomaticwomen,IPTspisgivenfreeofchargeas
directly observed therapy during the antenatal visit. Admin-
istration of two doses is recommended for HIV-negative
women and three doses for HIV-positive women.
2.2. Study Population, Enrolment, and Data Collection. All
women from whom we obtained written informed consent
were eligible for the study immediately after delivery. A study
midwifeadministeredastandardizedquestionnairetorecord
sociodemographic data (age, residence area, literacy, number
of gravidities, and monthly income), HIV serological status,
intake of antimalarial medications (IPTsp and other anti-
malarial prescriptions), and bed net use.
Malaria prevalence of 30% at the time of childbirth was
used as a proxy to calculate the sample size in this study.
Thus, a number of 323 women was necessary assuming 90%
power at 5% signiﬁcance level.
Because of lack of an ethical committee in the CAR, this
project was reviewed and approved by an ad hoc scientiﬁc
committee of the University of Bangui in charge of validating
scientiﬁcstudyprotocolsintheCAR.Thestudywasconduct-
ed under a collaborative agreement with the University of
Marseille, France.
2.3. Laboratory Analyses. Peripheral venous and placental
blood from each woman was used to prepare thick blood
ﬁlms. Placental blood was obtained as follows: immediately
after delivery, the paracentric side of the maternal placenta
was cleaned with sterile water and incised, and thick blood
ﬁlms were prepared from a droplet collected by aspiration
through a 21-gauge needle attached to a 5-mL syringe, as
described previously [12, 13].
The thick smears were air-dried and stained with 4%
Giemsa.Ateachofthetwostudysites,anexperiencedmicro-
scopist immediately examined the stained smears by light
microscopy (×100 oil immersion) to detect asexual forms of
P. falciparum malaria parasites. On peripheral blood slides,
malaria parasites were counted in 200 leukocytes, and the
parasite density per microlitre of blood was estimated as
the number of parasites counted multiplied by 40 under
the assumption of a leukocyte count of 8000/µL of blood.
For both types of blood ﬁlm, a result was considered to be
negative if no parasites were detected per 200 leukocytes.
Women with a positive peripheral blood result were given
antimalarial treatment (either artemether-lumefantrine or
quinine, depending on a clinical evaluation and individual
tolerance).
AlltheslideswereanalysedtwiceattheBiomedicalLabo-
ratory of the Institut Pasteur de Bangui.
2.4. Data Analysis. Data were double-entered into EpiInfo
softwareversion3.5.1,andthedatabasewascheckedanddata
entry errors corrected with the EpiInfo software “data com-
pare” utility for ﬁnding diﬀerences between two tables. Sta-
tistical analysis was conducted with Stata 8.0 and MedCalc
v11.6.1. The association between sociodemographic criteria
and malaria, use of IPTsp and ITNs was examined using
the chi-squared test, and association between those variables
was tested by calculating the odds ratios (ORs). The esti-
mates were achieved at 95% interval conﬁdence. Diﬀerences
between proportions ≤5% were considered as signiﬁcant.
3. Results
3.1. Study Population Characteristics. Overall, 328 pregnant
women delivering at the two health centres were included
in the study: 168 (51.2%) at the Castors and 160 (48.8%) at
the “Communautaire” Hospital. A large proportion of them
reside in Bangui city (96.0% or 314/328). The mean age
was 23 years (range, 14–39 years), and 33.8% were aged less
than twenty years. A proportion of 33.0% (108/328) were
primigravid. Most of those women do not have any personal
monthly income (57.9%), but the majority of them have at
least secondary educational status.
HIV infection had been screened for 58.2% (191/328)
of the population, resulting an infection prevalence of 9.1%Journal of Tropical Medicine 3
M1 M2 M3 M4 M5 M6 M7 M8 M9
0
5
10
15
20
25
30
(
%
)
Gestational age (months)
Castors (n = 105)
Communautaire (n = 127)
Figure 1: First antenatal clinic attendance according to gestational
age, September 2009, Central African Republic.
(15/164; 27 HIV results could not be cross-checked on the
antenatal clinic cards).
Sleepingdailyunderbednetwasreportedby81.5%(95%
CI, [77.3–85.7]) of the women, and 42.4% (95% CI, [36.8–
48.0]) had ITNs.
3.2. Attendance at Antenatal Clinics. At the two study sites,
checking of antenatal clinic cards showed that 93.3% (95%
CI, [90.8–95.8]) of the women had presented at least one
antenatal visit. Less than one fourth of the women (24.1%;
95%CI,[19.3–28.9]) hadattendedanantenatalclinicduring
the ﬁrst trimester of pregnancy, while the majority (55.6%;
95%CI,[50.0–61.2])hadattendedaclinicduringthesecond
trimester. Overall, 35.6% (95% CI, [31.1–40.1]) completed
four antenatal visits. The distribution of ﬁrst antenatal
attendance according to gestational age at each study site is
shown in Figure 1.
3.3. Any Antimalarial Treatment during the Pregnancy. Of
the women who received IPTsp, 75.4% (95% CI, [69.1–
81.8]) were given curative prescriptions of other antimalarial
drugs, independently of the timing of IPTsp doses (Figure 2).
The antenatal clinic cards of 182 women (55.5%; 95%
CI, [50.1–60.1]) showed a history of at least one curative
treatment for malaria. Of these women, 27.0% had been
prescribedanantimalarialdrugtwoorthreetimes.Although
228 antimalarial prescriptions were recorded on antenatal
clinic cards during the current pregnancy, only 56 laboratory
results were positive out of the total 73 blood smears
analysed. The antimalarial drugs prescribed were quinine
(66.7% or 152/228; 95% CI, [60.6–72.8]), artemisinin-based
combinations (15.5%; 95% CI, [10.7–20.1]) and artemisinin
monotherapy (18.0%; 95% CI, [13.0–23.0]).
At least one dose of IPTsp was recorded for 54.6% (95%
CI, [49.2–60.0]) of our study population; only 30.5% (95%
CI, [23.8–37.2]) had received at least two doses. Most of
these women (78.2%; 95% CI, [72.2–84.3]) had received the
ﬁrst IPTsp dose between the fourth and seventh months
of pregnancy; however, 11.7% (95% CI, [7.0–16.4]) had
A: IPTsp only
B: Other antimalarial only
C: IPTsp and other antimalarial
D: No history of antimalarial
B
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Figure 2: Distribution of antimalarial (IPTsp or any other antimal-
arial) use during pregnancy, September 2009, Central African
Republic. IPTsp: intermittent preventive treatment with sulfadoxi-
ne-pyrimethamine.
received the ﬁrst dose during the ﬁrst trimester. Details of
IPTsp administration are shown in Figure 3.
3.4. Relation between Sociodemographic Characteristics and
the Compliance to Malaria Prevention. Multigravid women,
were less likely to use two doses of IPTsp (OR = 0.14; 95%
CI, [0.08–0.24], P<0.0001) and ITNs (OR = 0.16; 95% CI,
[0.10–0.28], P<0.001) compared to primigravid women.
Use of IPTsp (two doses) was associated with lucrative
activities(OR=4.20;[2.55–6.92],P<0.0001)andsecondary
or university educational status (OR = 2.22; 95% CI, [1.33–
3.72], P = 0.002). Women with secondary or university
e d u c a t i o n a ls t a t u sw e r ea l s ol i k e l yt ou s eI N T s( O R= 1.90;
95% CI, [1.20–3.01], P = 0.01). Details on association anal-
ysis between sociodemographic characteristics and those
preventive tools use are shown in Table 1.
3.5.ResultsofBloodSmearExaminations. Overall,peripheral
blood P. falciparum infection at delivery was found in
2.8% (95% CI, [1.0–4.6]) of peripheral blood and in 4.0%
(95% CI, [2.0–6.0]) of placental blood. Of the women with
placental malaria, 77.0% (10/13) declared not using any bed
net and 53.8% (7/13) had not taken any antimalarial drug
during pregnancy.
HIV serological status had no impact on these ﬁndings.
IPTsp and ITNs use was found not to be associated with
the women sociodemographical characteristics. Moreover,
there is no statistically signiﬁcant association between these
laboratory ﬁndings and those characteristics.4 Journal of Tropical Medicine
Table 1: Associationbetween some sociodemographic characteristics and the compliance to intermittent preventive treatment with sulfado-
xine-pyrimethamine (IPTsp) and insecticide-treated nets (INTs) in Bangui, September 2009, Central African Republic.
≥2 doses of IPTsp Use of ITNs
Criteria n % OR [95% CI] P-value % OR [95% CI] P-value
Age (years)
<20 111 36.9 1 NA 48.6 1 NA
20–24 105 27.6 0.65 [0.36–1.15] 0.18 40.0 0.70 [0.41–1.20] 0.25
25–29 74 27.0 0.63 [0.33–1.20] 0.21 29.7 0.44 [0.23– 0.83] 0.01
≥30 38 26.3 0.60 [0.26–1.38] 0.32 55.3 1.30 [0.62–2.73] 0.6
Gravidity
1 108 58.3 1 NA 70.4 1 NA
≥2 220 16.8 0.14 [0.08–0.24] <0.0001 28.6 0.16 [0.10–0.28] <0.001
Monthly income
No income 190 17.9 1 NA 46.3 1 NA
Salary or other personal income 138 47.8 4.20 [2.55– 6.92] <0.0001 37.0 0.67 [0.43–1.06] 0.11
Educational status
None or primary 130 20.8 1 NA 33.1 1 NA
Secondary or university 198 36.9 2.22 [1.33–3.72] 0.002 49.5 1.90 [1.20–3.01] 0.01
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Figure 3: Distribution of intermittent preventive treatment with
sulfadoxine-pyrimethamine (IPTsp) doses by gestational age, Sep-
tember 2009, Central African Republic.
4. Discussion
The prevalence of malaria among pregnant women in the
CAR (2.8% of thick peripheral blood smears and 4.0% of
placental slides) was lower than in other areas of intense
malaria transmission, such as Gabon, where the rates were
34.4% in maternal blood and 53.6% in placental blood
ﬁlms [6]. A recent review [14] of randomized clinical trials
and surveys on the eﬃcacy of IPT showed overall placenta-
positive rates ≥10%. Falade and coauthors [7] in Nigeria
reported that the prevalence of placental parasitaemia was
10.5% in women given IPTsp and 17% in those with no
chemoprophylaxis.
Three years after initiation of IPTsp in CAR, coverage
with at least one dose of IPTsp was slightly more than 50%.
Although WHO recommends two doses IPTsp for ≥80%
of pregnant women [15], our estimate in this study was
30.5%. The low prevalence of placental malaria in our study
is therefore probably due to the combination of IPTsp, other
antimalarial drug, and use of ITNs. Hence, the relatively low
prevalence of malaria at delivery is not surprising in Bangui.
Indeed, a similar ﬁnding of malaria prevalence at the time
of delivery is observed in Cˆ ote d’Ivoire, where Vanga-Bosson
and coauthors report a prevalence of 4.8% of placental
malaria,inanareawhereIPTspcoveragerate(≥2doses)does
not exceed 50% [16] and, in Thailand, where proportion
of positive results for P. falciparum in maternal blood and
in placental blood were estimated at 3.0% and 3.8%,
respectively [17]. In Thailand, the authors report that this
relative lower prevalence was due to antimalarial treatment
with artemisinin derivatives. In our study, most of women
were prescribed quinine or artemisinin-based combinations
during the pregnancy. Indeed, those antimalarial drugs are
actually the most eﬃcacious on malaria [18].
Otherwise, our ﬁndings show that more than 80% of
the women slept under a bed net. The eﬃcacy of bed nets
for preventing malaria is indisputable. Indeed, use of ITNs
wasfoundtoreduce the incidence of uncomplicatedmalarial
episodes in areas of stable malaria by 50% in comparison
with no nets use and by 39% in comparison with untreated
nets use [15].
In our study, the lower proportion of use of IPTsp and
ITNs in multigravid women could be due to less health
conscious of those women of their pregnancy. Inversely,Journal of Tropical Medicine 5
the relative high proportion of use of IPTsp and ITNs in
women with high level of education is due to the fact that
higher educational status implies more health consciousness
and is a factor inﬂuencing assimilation of health education
programmes. Similar ﬁndings were reported in Cameroon
andin Malawi[19,20]. Womenwith salary or other personal
income are also likely to be compliant with IPTsp and ITNs,
possibly because they are able to aﬀord health care fees.
Themainlimitationofourstudyistheonlyuseofmicro-
scopic examination of blood smears. Even if, the micro-
scopic analysis remains the standard detection of Plasmod-
ium [21], submicroscopic infections are common during
pregnancy [21, 22]. Hence, molecular methods (polymerase
chain reaction or PCR) and rapid diagnostic tests (RDTs)
provide ﬁnding approximately twice as many infections as
microscopy [23–25]. However, determination of the possible
impact of these submicroscopic infections to poor birth
outcomes and maternal health is critical [26], and PCR is
not feasible routinely [27]. To this end, microscopic exami-
nationtodetecttheseinfectionsisstillessential,andimplem-
entation of RDTs use is challenging [21, 28].
5. Conclusion
Our results indicate that, although the recommended cover-
age rates of pregnant women with IPTsp and ITNs are not
reached in Bangui, the prevalence of the main indicator of
infection, placental malaria, is relatively low. The widespread
presumptive prescription and consumption of antimalarial
agents could indisputably be the cause of clearance of the
existing peripheral and placental Plasmodium infection and
decreased the risk of new infections over the pregnancy
period. Indeed, symptoms suggestive of malaria are very fre-
quent among pregnant women attending antenatal clinics,
thus implying frequently unnecessary large use of antimalar-
ialdrugs[29].Forthispurpose,strengtheningnationalmala-
ria control activities, taking into account prompt laboratory
diagnosis and sociodemographic particularities, should con-
tribute to the achievement of high coverage rate with the
WHO preventive package components. Otherwise, cohort
studies are needed to assess the real eﬃcacy of IPTsp in pre-
venting malaria during pregnancy.
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